GOZETOTIDE
GOZETOTIDE is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Gozellix. Available dosage form: kit.
Drug details
- Generic Name
- GOZETOTIDE
- Brand Names
- Gozellix
- Application Number
- NDA219592
- Sponsor
- Telix Innovations SA
- NDC Codes
- 1
- Dosage Forms
- KIT
Indications and Usage
1 INDICATIONS AND USAGE GOZELLIX, after radiolabeling with Ga 68, is indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: With suspected metastasis who are candidates for initial definitive therapy. With suspected recurrence based on elevated serum prostate-specific antigen (PSA) level. GOZELLIX, after radiolabeling with Ga 68, is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: With suspected metastasis who are candidates for initial definitive therapy. With suspected recurrence based on elevated serum prostate-specific antigen (PSA) level. ( 1 )